Recent development in the design of sialyltransferase inhibitors
β Scribed by Xiaofang Wang; Li-He Zhang; Xin-Shan Ye
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 210 KB
- Volume
- 23
- Category
- Article
- ISSN
- 0198-6325
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Sialylation at the nonβreducing end of glycoconjugates is an important biological process in cellular recognitions, tumor metastases, and immune responses, which are mediated by a family of enzymes known as sialyltransferases. Inhibition of sialyltransferases may prove useful in elucidating the biological functions of sialylation and may have therapeutic applications. This review summarizes the recent development in this field with particular focus on the strategies used for the design of carbohydrate mimetics and the structureβactivity relationships of substrateβbased sialyltransferase inhibitors. Β© 2002 Wiley Periodicals, Inc. Med Res Rev, 23, No. 1, 32β47, 2003; Published online in Wiley InterScience (www.interscience.wiley.com). DOI 10.1002/med.10030
π SIMILAR VOLUMES
## Abstract Human cytomegalovirus (HCMV) is one of the most common opportunistic infections in immunucompromised individuals, such as AIDS patients and organ transplant recipients, and is the most frequent congenital viral infection in humans. Despite a reduction of the incidence of AIDSβrelated op